Segall Bryant & Hamill LLC Buys Shares of 288,100 Azenta, Inc. (NASDAQ:AZTA)

Segall Bryant & Hamill LLC purchased a new stake in Azenta, Inc. (NASDAQ:AZTA) in the fourth quarter, HoldingsChannel reports. The firm purchased 288,100 shares of the company’s stock, valued at approximately $14,405,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Victory Capital Management Inc. increased its holdings in Azenta by 4.0% during the 3rd quarter. Victory Capital Management Inc. now owns 27,281 shares of the company’s stock valued at $1,321,000 after acquiring an additional 1,061 shares in the last quarter. Cerity Partners LLC increased its stake in shares of Azenta by 21.2% during the 3rd quarter. Cerity Partners LLC now owns 39,031 shares of the company’s stock worth $1,891,000 after purchasing an additional 6,840 shares in the last quarter. BNP Paribas Financial Markets raised its position in shares of Azenta by 285.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 31,227 shares of the company’s stock worth $1,513,000 after purchasing an additional 23,132 shares during the last quarter. Glenmede Trust Co. NA lifted its stake in Azenta by 6.3% in the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company’s stock valued at $551,000 after buying an additional 679 shares in the last quarter. Finally, Verition Fund Management LLC acquired a new stake in Azenta during the 3rd quarter valued at $873,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on AZTA shares. Stephens restated an “overweight” rating and issued a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Evercore ISI upped their target price on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. Needham & Company LLC lifted their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a “buy” rating in a report on Thursday, February 6th. Finally, TD Cowen raised shares of Azenta to a “hold” rating in a research note on Thursday, February 27th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $58.75.

Azenta Price Performance

NASDAQ AZTA opened at $37.15 on Wednesday. Azenta, Inc. has a 12 month low of $35.56 and a 12 month high of $63.58. The company has a 50-day moving average of $46.13 and a 200-day moving average of $46.49. The company has a market cap of $1.70 billion, a P/E ratio of -12.47 and a beta of 1.52.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, equities research analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.